Is A Holding Company That’s Invested In More Than A Half-dozen Cannabidiol (cbd)-product Companies For The Pharmaceutical, Nutraceutical, Cosmeceutical, Or Industrial Hemp Industries.

Rolling dice that read "buy" or "sell" on top of a digital stock chart. ( NASDAQOTH:MJNA ). While GW Pharmaceuticals currently holds the title of being the largest pot stock by a mile, Medical Marijuana, Inc. holds the distinction of being the first publicly listed marijuana stock. Unlike most marijuana stocks that tend to focus on developing a handful of products or a small portfolio of cannabinoid-based drugs, Medical Marijuana, Inc. is a holding company that’s invested in more than a half-dozen cannabidiol (CBD)-product companies for the pharmaceutical, nutraceutical, cosmeceutical, or industrial hemp industries. The company’s eight listed subsidiaries and investments include: HempMeds, which offers marketing and sales of CBD-based products in the U.S.; Kannaway, which specializes in hemp-based botanical products; KannaLife Sciences, which is a cannabinoid-based drug developer; Axim Biotechnologies, which is also a developer of cannabinoid-based medicines; MPS International, a security consultation service for the weed industry; Wellness Managed Services, which provides support services to the pot industry. The most obvious reason marijuana stock investors are Green Rush likely excited about a company like Medical Marijuana, Inc. is its portfolio diversity. Its complete ownership of HempMeds and investments in KannaLife Sciences and Axim Biotechnologies gives the company access to retail CBD product sales, as well as the opportunity to earn significant investment rewards if Axim’s and KannaLife’s cannabinoid-based products succeed in clinical trials.

To read more visit https://www.fool.com/investing/2017/06/16/better-know-a-marijuana-stock-medical-marijuana-in.aspx

Truth Is, I Won’t Touch A Cannabis Company That Doesn’t Have A War Chest Of Capital Going Into 2018.

And only those companies that are well capitalized will be able to successfully compete in 2018. Truth is, I won’t touch a cannabis company that doesn’t have a war chest of capital going into 2018. The market is getting too competitive, and those that are not well capitalized will be out of business by the end of next year. Market share is also incredibly important. This is where Canada really shines, as the biggest players in this market also have exposure in other countries, including the U.S., Germany, Colombia, Israel, and Australia. Medical marijuana And, of course, management is key. In fact, I often say that it’s management in which I invest, not companies. Similar to the way we’ve seen this factor play a role in the success of stocks like Tesla (NASDAQ: TSLA), Amazon (NASDAQ: AMZN), and Apple (NASDAQ: AAPL), the same holds true of the cannabis space. As an expert in this field, I’ve come to know and respect the most successful management teams in this space.

To read more visit https://www.energyandcapital.com/articles/the-top-7-cannabis-stocks-for-2018/6104